Chemotherapy
Approved for: NSCLC
Paclitaxel Albumin-Stabilized Nanoparticle Formulation (Abraxane) approved Chemotherapy for Non-small cell lung cancer (NSCLC) that is locally advanced or has metastasized. It is used with carboplatin as first-line treatment in patients whose disease cannot be treated with surgery or radiation therapy.
